ASRS
URGN icon

Arizona State Retirement System’s UroGen Pharma URGN Stock Holding History

Arizona State Retirement System’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Sell
10,746
-55
-0.5% -$1.49K ﹤0.01% 1645
2026
Q1 		$194K Buy
+10,801
New +$217K ﹤0.01% 1914

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Arizona State Retirement System's URGN Position: Q2 2026 in Review

Arizona State Retirement System reduced its UroGen Pharma (URGN) stake by 0.51% in Q2 2026, selling an estimated $1.49K and leaving 10,746 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Arizona State Retirement System first reported a position in URGN in Q1 2026 and has held it in 2 quarters since. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Arizona State Retirement System held 10,746 shares of UroGen Pharma worth $395K as of Q2 2026.
  • Arizona State Retirement System sold 55 UroGen Pharma shares in Q2 2026, an estimated $1.49K.
  • UroGen Pharma made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1645 holding.
  • Arizona State Retirement System first reported a position in UroGen Pharma in Q1 2026 and has held it in 2 quarters since.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.